Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-01-08 Sale |
2021-01-11 5:59 pm |
Black Diamond Therapeutics Inc. | BDTX | Leggett Thomas Chief Financial Officer |
3,000 | $33.94 | $101,820 | 218,171 (Direct) |
View |
| 2020-12-08 Sale |
2020-12-10 4:16 pm |
Black Diamond Therapeutics Inc. | BDTX | Leggett Thomas Chief Financial Officer |
3,000 | $33.78 | $101,327 | 221,171 (Direct) |
View |
| 2020-11-09 Sale |
2020-11-12 5:00 pm |
Black Diamond Therapeutics Inc. | BDTX | Leggett Thomas Chief Financial Officer |
3,000 | $32.96 | $98,892 | 224,171 (Direct) |
View |
| 2020-10-08 Sale |
2020-10-09 4:12 pm |
Black Diamond Therapeutics Inc. | BDTX | Leggett Thomas Chief Financial Officer |
3,000 | $33.53 | $100,576 | 227,171 (Direct) |
View |
| 2020-09-14 Sale |
2020-09-16 6:09 pm |
Black Diamond Therapeutics Inc. | BDTX | Leggett Thomas Chief Financial Officer |
3,000 | $31 | $93,000 | 230,171 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-20 Option Award |
2025-03-20 6:17 pm |
N/A 2035-03-19 |
Stoke Therapeutics Inc. | STOK | Leggett Thomas Chief Financial Officer |
148,000 | $0 | 148,000 (Direct) |
View |
| 2024-05-15 Option Award |
2024-05-17 4:14 pm |
N/A 2034-05-14 |
Stoke Therapeutics Inc. | STOK | Leggett Thomas Chief Financial Officer |
396,200 | $0 | 396,200 (Direct) |
View |
Ownership |
2021-03-17 9:45 pm |
N/A N/A |
Research Alliance Corp. II | RACB | Leggett Thomas Director |
0 | $0 | 30,000 (Direct) |
View |
| 2021-02-17 Option Award |
2021-02-19 6:47 pm |
N/A 2031-02-16 |
Black Diamond Therapeutics Inc. | BDTX | Leggett Thomas Chief Financial Officer |
75,000 | $0 | 75,000 (Direct) |
View |
| 2021-01-08 Exercise |
2021-01-11 5:59 pm |
N/A N/A |
Black Diamond Therapeutics Inc. | BDTX | Leggett Thomas Chief Financial Officer |
3,000 | $10.86 | 218,171 (Direct) |
View |
| 2021-01-08 Exercise |
2021-01-11 5:59 pm |
N/A 2029-09-08 |
Black Diamond Therapeutics Inc. | BDTX | Leggett Thomas Chief Financial Officer |
3,000 | $0 | 218,171 (Direct) |
View |
| 2020-12-08 Exercise |
2020-12-10 4:16 pm |
N/A N/A |
Black Diamond Therapeutics Inc. | BDTX | Leggett Thomas Chief Financial Officer |
3,000 | $10.86 | 221,171 (Direct) |
View |
| 2020-12-08 Exercise |
2020-12-10 4:16 pm |
N/A 2029-09-08 |
Black Diamond Therapeutics Inc. | BDTX | Leggett Thomas Chief Financial Officer |
3,000 | $0 | 221,171 (Direct) |
View |
| 2020-11-09 Exercise |
2020-11-12 5:00 pm |
N/A N/A |
Black Diamond Therapeutics Inc. | BDTX | Leggett Thomas Chief Financial Officer |
3,000 | $10.86 | 224,171 (Direct) |
View |
| 2020-11-09 Exercise |
2020-11-12 5:00 pm |
N/A 2029-09-08 |
Black Diamond Therapeutics Inc. | BDTX | Leggett Thomas Chief Financial Officer |
3,000 | $0 | 224,171 (Direct) |
View |
| 2020-10-08 Exercise |
2020-10-09 4:12 pm |
N/A N/A |
Black Diamond Therapeutics Inc. | BDTX | Leggett Thomas Chief Financial Officer |
3,000 | $10.86 | 227,171 (Direct) |
View |
| 2020-10-08 Exercise |
2020-10-09 4:12 pm |
N/A 2029-09-08 |
Black Diamond Therapeutics Inc. | BDTX | Leggett Thomas Chief Financial Officer |
3,000 | $0 | 227,171 (Direct) |
View |
| 2020-09-14 Exercise |
2020-09-16 6:09 pm |
N/A N/A |
Black Diamond Therapeutics Inc. | BDTX | Leggett Thomas Chief Financial Officer |
3,000 | $10.86 | 230,171 (Direct) |
View |
| 2020-09-14 Exercise |
2020-09-16 6:09 pm |
N/A 2029-09-08 |
Black Diamond Therapeutics Inc. | BDTX | Leggett Thomas Chief Financial Officer |
3,000 | $0 | 230,171 (Direct) |
View |